← All trials

NCT05737173

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Aug 3, 2020
Primary completion
Sep 1, 2022
Completion date
Oct 1, 2022
First posted
Feb 21, 2023
Last posted
Feb 21, 2023
Enrollment
93
Arms / groups
3 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.